SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-16-005662
Filing Date
2016-03-30
Accepted
2016-03-30 15:19:10
Documents
87
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K xenetic_10k-123115.htm 10-K 941663
2 CERTIFICATION xenetic_10k-ex3101.htm EX-31.1 12392
3 CERTIFICATION xenetic_10k-ex3102.htm EX-31.2 12362
4 CERTIFICATION xenetic_10k-ex3201.htm EX-32.1 4320
  Complete submission text file 0001019687-16-005662.txt   5116113

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20151231.xml EX-101.INS 882412
6 XBRL SCHEMA FILE xbio-20151231.xsd EX-101.SCH 49517
7 XBRL CALCULATION FILE xbio-20151231_cal.xml EX-101.CAL 75281
8 XBRL DEFINITION FILE xbio-20151231_def.xml EX-101.DEF 254478
9 XBRL LABEL FILE xbio-20151231_lab.xml EX-101.LAB 387151
10 XBRL PRESENTATION FILE xbio-20151231_pre.xml EX-101.PRE 365127
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-178082 | Film No.: 161539146
SIC: 2834 Pharmaceutical Preparations